Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study

Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Switzerland, as well as risk factors for infection and symptoms associated with IgG seropositivity. Methods: Between April and June 2020, former participants of a representative survey of the 20–74-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Aude, Wisniak, Ania, Perez-Saez, Javier, Garrison-Desany, Henri, Petrovic, Dusan, Piumatti, Giovanni, Baysson, Hélène, Picazio, Attilio, Pennacchio, Francesco, De Ridder, David, Chappuis, François, Vuilleumier, Nicolas, Low, Nicola, Hurst, Samia, Eckerle, Isabella, Flahault, Antoine, Kaiser, Laurent, Azman, Andrew S., Guessous, Idris, Stringhini, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808008/
https://www.ncbi.nlm.nih.gov/pubmed/34664529
http://dx.doi.org/10.1177/14034948211048050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808008/
https://www.ncbi.nlm.nih.gov/pubmed/34664529
http://dx.doi.org/10.1177/14034948211048050

Ejemplares similares